Attività di Ricerca

In questa sezione sono segnalate le pubblicazioni scientifiche, tra i cui autori sono presenti i medici del team di Affidea IRMET.

 

01/2018
Imaging and Intervention in Urinary Tract Infections and Urosepsis. “Nuclear Medicine in the Manage ment of Patient with Kidneys Intracystic Infection”.

D Penna, V Militano, V Arena, A Cistaro, E Pelosi. 127-141. Ed. M Tonolini, Springer, 2018

 

 

29/03/2017
A Rare Case of Hibernoma Occasionally Identified by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Patient with Lung Cancer.

Penna D, Quartuccio N, Testa C, Arena V, Cistaro A, Pelosi E.

Cureus. 2017 Mar 29;9(3):e1124. doi: 10.7759/cureus.1124.

 

 

31/01/2017
MRI and 18F-FDG-PET/CT in a rare case of early (precursor) B-lymphoblastic leukaemia with bone involvement as initial manifestation.

Cistaro A, La Delfa V, Di Rosa G, Cogoni M, Quartuccio N.

Nucl Med Rev Cent East Eur. 2017;20(1):57-59. doi: 10.5603/NMR.2017.0004.

 

 

01/2017
Nuclear Oncology. “Diagnostic Applications of Nuclear Medicine: Colorectal Cancer”.

E Pelosi, D Deandreis, L Cassalia, D Penna. Ed. W Strauss, G Mariani, D Volterrani, S Larson. 1-21. Springer, 2017

 

 

01/12/2016
Prevention of dental caries: A review of effective treatments.

Sicca C, Bobbio E, Quartuccio N, Nicolo G, Cistaro A.

J Clin Exp Dent. 2016 Dec 1;8(5):e604-e610. eCollection 2016 Dec. Review.

 

 

14/11/2016
Brain 18F-FDG PET/CT findings in a case of genetic Creutzfeldt-Jakob disease due to V203I heterozygous mutation in the PRNP gene.

Cistaro A, Cassalia L, Ferrara C, Atzori C, Vai D, Quartuccio N, Fania P, Vaudano GP, Imperiale D.

J Neurol. 2017 Jan;264(1):170-173. doi: 10.1007/s00415-016-8327-5. Epub 2016 Nov 14. No abstract available.

 

 

25/07/2016
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.

Chiavazza C, Cistaro A, Fania P, Bertolotto A, Cavalla P, Ruda R, Pinessi L, Soffietti R.

Neurol Sci. 2016 Dec;37(12):2019-2023. Epub 2016 Jul 25. No abstract available.

 

 

15/07/2016
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.

Marini C, Cistaro A, Campi C, Calvo A, Caponnetto C, Nobili FM, Fania P, Beltrametti MC, Moglia C, Novi G,

Buschiazzo A, Perasso A, Canosa A, Scialo C, Pomposelli E, Massone AM, Bagnara MC, Cammarosano S, Bruzzi P, Morbelli S, Sambuceti G, Mancardi G, Piana M, Chio A.

Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2061-71. doi: 10.1007/s00259-016-3440-3. Epub 2016 Jul 15.

 

 

26/05/2016
Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results.

Panichelli P, Villano C, Cistaro A, Bruno A, Barbato F, Piccardo A, Duatti A.

Cancer Biother Radiopharm. 2016 Jun;31(5):159-67. doi: 10.1089/cbr.2016.2028. Epub 2016 May 26.

 

 

19/02/2016
(18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.

Cistaro A, Cucinotta M, Cassalia L, Priola A, Priola S, Pappalardo M, Coppolino P, De Simone M, Quartuccio N.

Rev Esp Med Nucl Imagen Mol. 2016 Jul-Aug;35(4):232-7. doi: 10.1016/j.remn.2016.01.001. Epub 2016 Feb
English, Spanish.

 

 

24/12/2015
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis.

Pagani M, Oberg J, De Carli F, Calvo A, Moglia C, Canosa A, Nobili F, Morbelli S, Fania P, Cistaro A, Chio A.

Hum Brain Mapp. 2016 Mar;37(3):942-53. doi: 10.1002/hbm.23078. Epub 2015 Dec 24.

 

 

20/11/2015
18F-FDG-PET correlates of cognitive impairment in ALS.

Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, Cammarosano S, Ilardi A, Moglia C, Calvo A, Chio A.

Neurology. 2016 Jan 5;86(1):44-9. doi: 10.1212/WNL.0000000000002242. Epub 2015 Nov 20.

 

 

07/09/2015
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.

Ardito A, Massaglia C, Pelosi E, Zaggia B, Basile V, Brambilla R, Vigna-Taglianti F, Duregon E, Arena V, Perotti P, Penna D, Terzolo M.

Eur J Endocrinol. 2015 Dec;173(6):749-56. doi: 10.1530/EJE-15-0707. Epub 2015 Sep 7.

 

 

31/07/2015
124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.

Cistaro A, Quartuccio N, Caobelli F, Piccardo A, Paratore R, Coppolino P, Sperandeo A, Arnone G, Ficola U.

Nucl Med Rev Cent East Eur. 2015;18(2):102-6. doi: 10.5603/NMR.2015.0024.

 

 

29/06/2015
Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.

Cistaro A, Niccoli Asabella A, Coppolino P, Quartuccio N, Altini C, Cucinotta M, Alongi P, Balma M, Sanfilippo S, Buschiazzo A, Piccardo A, Fanelli M, Sambuceti G, Bomanji J, Baldari S, Bisi G, Fanti S, Rubini G.

Hell J Nucl Med. 2015 May-Aug;18(2):97-102. doi: 10.1967/s002449910202. Epub 2015 Jun 29.

 

 

06/2015
Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.

Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, Rubini D, Cistaro A, Montemurro S, Rubini G.

Abdom Imaging. 2015 Jun;40(5):1190-202. doi: 10.1007/s00261-014-0277-8.

 

 

19/02/2015
Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Mellai M, Piazzi A, Casalone C, Grifoni S, Melcarne A, Annovazzi L, Cassoni P, Denysenko T, Valentini MC, Cistaro A, Schiffer D.

Onco Targets Ther. 2015 Feb 19;8:451-60. doi: 10.2147/OTT.S71384. eCollection 2015.

 

 

01/2015
Pediatric bone sarcoma: diagnostic performance of 1⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.

Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schoder H.

AJR Am J Roentgenol. 2015 Jan;204(1):153-60. doi: 10.2214/AJR.14.12932.

 

 

10/11/2014
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes.

Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M.

Lancet Neurol. 2014 Dec;13(12):1228-40. doi: 10.1016/S1474-4422(14)70167-X. Epub 2014 Nov 10. Review.

 

 

06/11/2014
Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?

Quartuccio N, Van Weehaeghe D, Cistaro A, Jonsson C, Van Laere K, Pagani M.

Q J Nucl Med Mol Imaging. 2014 Dec;58(4):344-54. Epub 2014 Nov 6. Review.

 

 

20/10/2014
18F-FDG-PET/CT in a Patient with Suspected Large Vessel Vasculitis.

Penna D, Testa C, Arena V, Pelosi E.

J Clin Diagn Res. 2014 Oct;8(10):RJ02-3. doi: 10.7860/JCDR/2014/8283.5035. Epub 2014 Oct 20. No abstract available.

 

 

16/10/2014
Uncommon 18F-FDG-PET/CT findings in patients affected by limbic encephalitis: hyper-hypometabolic pattern with double antibody positivity and migrating foci of hypermetabolism.

Cistaro A, Caobelli F, Quartuccio N, Fania P, Pagani M.

Clin Imaging. 2015 Mar-Apr;39(2):329-33. doi: 10.1016/j.clinimag.2014.09.004. Epub 2014 Oct 16.

 

 

15/08/2014
A strange case of phyllodes tumor detected using (18)F-FDG PET/CT in an adolescent patient affected by Hodgkin lymphoma: a possible pitfall.

Cucinotta M, Quartuccio N, Coppolino P, La Delfa V, Bianchi M, Fagioli F, Cistaro A.

Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):e201-5. doi: 10.1016/j.clml.2014.06.106. Epub 2014 Aug 15.

No abstract available.

 

 

13/08/2014
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.

Pagani M, Chio A, Valentini MC, Oberg J, Nobili F, Calvo A, Moglia C, Bertuzzo D, Morbelli S, De Carli F, Fania P, Cistaro A.

Neurology. 2014 Sep 16;83(12):1067-74. doi: 10.1212/WNL.0000000000000792. Epub 2014 Aug 13.

 

 

29/04/2014
Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis.

Carbone RG, Penna D, Baughman RP, Lower EE.

J Clin Imaging Sci. 2014 Apr 29;4:21.

 

 

10/04/2014
Role of PET and SPECT in the study of amyotrophic lateral sclerosis.

Cistaro A, Cuccurullo V, Quartuccio N, Pagani M, Valentini MC, Mansi L.

Biomed Res Int. 2014;2014:237437. doi: 10.1155/2014/237437. Epub 2014 Apr 10. Review.

 

 

30/04/2014
1⁸F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study.

Piccardo A, Puntoni M, Bertagna F, Treglia G, Foppiani L, Arecco F, Giubbini R, Naseri M, Cistaro A, Cabria M, Bardesono F, Ceriani L, Orlandi F, Giovanella L.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91. doi: 10.1007/s00259-014-2774-y. Epub 2014 Apr 30.

 

 

25/04/2014
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment.

Canosa A, Calvo A, Moglia C, Iazzolino B, Brunetti M, Restagno G, Cistaro A, Fania P, Carrara G, Valentini MC, Tanel R, Chio A.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1437-9. doi: 10.1136/jnnp-2013-307552. Epub 2014 Apr 25.

No abstract available.

 

 

22/02/2014
Prognostic value of 1⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1046-56. doi: 10.1007/s00259-014-2691-0. Epub 2014 Feb 22.

 

 

21/01/2014
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients.

Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chio A.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):844-52. doi: 10.1007/s00259-013-2667-5. Epub 2014 Jan 21.

 

 

03/10/2014
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

Autore: M. Pagani, A. Chiò, M. C. Valentini, J. Oberg, F. Nobili, A. Calvo, C. Moglia, D. Bertuzzo, S. Morbelli, F. de Carli, P. Fania, A. Cistaro

We investigated a large sample of patients with amyotrophic lateral sclerosis (ALS) at rest in order to assess the value of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) PET as a biomarker to discriminate patients from controls.

 

 

31/01/2014
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

Autore: Brunetti M., Calvo A., Canosa A., Carrara G., Chiò A., Cistaro A., Fania P., Lopiano L., Moglia C., Montuschi A., Nobili F., Pagani M., Restagno G., Traynor B.J., Valentini M.C.

Tratto da: Springer

Recently, a GGGGCC hexanucleotide repeat expansion in the C9ORF72 gene, located on chromosome 9p21 has been demonstrated to be the commonest cause of familial amyotrophic lateral sclerosis (ALS) and to account for 5 to 10 % of apparently sporadic ALS.
2014 January 21

 

 

09/01/2014
Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma

Autore: Ardissone F., Arena V., Billè A., Errico L., Okiror L., Pelosi E., Penna D., Skanjeti A.

Tratto da: European Journal of Cardio-Thoracic Surgery

The aim of our study was to analyze the specificity and sensitivity of integrated positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology (adenocarcinoma vs squamous cell carcinoma), and to identify the factors related to false-negative findings.
2012 June 11

 

 

09/01/2014
The Prognostic Significance of Maximum Standardized Uptake Value of Primary Tumor in Surgically Treated Non-Small-Cell Lung Cancer Patients: Analysis of 413 Cases

Autore: Ardissone F., Arena V., Billè A., Errico L., Okiror L., Pelosi E., Penna D., Skanjeti A.

Tratto da: Clinical Lung Cancer, Vol. 14, N. 2, 149-56

We assessed the prognostic significance of tumor maximum standardized uptake value (SUVmax) at positron emission tomography and computed tomography (PET/CT) in surgically resected lung cancer patients and whether a novel standardized SUV ratio of tumor SUVmax to liver or blood pool SUVmax was additionally prognostically significant in 413 patients. Tumor SUVmax was an independent prognostic factor but both ratios were not. Our results could help plan adjuvant treatment.
2013 March

 

 

10/10/2013
18F-FDG-PET/CT in a patient with suspected recurrence of germ cell tumor

Autore: Penna D, Arena V, Pelosi E

Tratto da: J Cancer Res Ther 2013, July-September

 

 

05/09/2013
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification.

Autore: A. Cistaro, N. Quartuccio, A. Mojtahedi, P. Fania, P. L. Filosso, A. Campennì, U. Ficola, S. Baldari

Tratto da: Radiology and Oncology 2013; 47(3)

Purpose: to evaluate the correlation between SUV max, size of primary lung lesion, disease-free Survival (DFS) and overall survival (OS) in patients with stage I and II NSCLC in 2 years follow-up.

 

 

14/06/2013
Diffuse neoplasms of the pleural serosa

Autore: Cardinale L, Ardissone F, Asteggiano F, Laugelli EM, Penna D, Fava C

Tratto da: Radiol Med. 2012 Sep 17

 

 

14/06/2013
Dual-phase F18-FDG-PET/CT scanning in the suspicion of relapse of ovarian neoplasia

Autore: Penna D, Varetto T, Deandreis D, Castellano G, Bisi G

Tratto da: Clin Nucl Med.
2009 Feb.

 

 

10/06/2013
Diagnostic performance of Fluorine-18-Fluorodeoxy-glucose positron emission tomography in patients with chronic inflammatory bowel disease: A systematic review and a meta-analysis

Autore: G. Treglia, N. Quartuccio, R. Sadeghi, A. Farchione, C. Caldarella, F. Bertagna, P. Fania, A. Cistaro

Objective: To systematically review and meta-analyze published data about the diagnostic performance of 18F-FDG PET and PET/CT in patients with chronic inflammatory bowel disease.

 

 

10/06/2013
The role of PET in inflammatory bowel disease

Autore: A. Cistaro, N. Quartuccio, L. Mansi, A. Signore, M. Dolci, G. Treglia

IBD are a group of pathological conditions characterized by chronic inflammation of the gastrointestinal tract, including Crohn's disease and ulcerative colitis.

 

 

10/06/2013
Brain hypermetabolism in ALS: a FDG PET study in ALS of spinal and bulbar onset

Autore: A. Cistaro, M. C. Valentini, A. Chiò, F. Nobili, A. Calvo, C. Moglia, A. Montuschi, S. Morbelli, D. Salmaso, P. Fania, G. Carrara, M. Pagani

Purpose: To identify the neurobiological traits of amyotrophic lateral sclerosis (ALS) and to elucidate functional differences between ALS of spinal and bulbar onset.

 

 

14/03/2013
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma

Autore: N. Quartuccio, G. Treglia, M. Salsano, M. V. Mattoli, B. Muoio, A. Piccardo, E. Lopci, A. Cistaro

The objective of this study is to systematically review the role of PET and PET/CT with Fluorine-18-Fluorodeoxyglucose (FDG) in patients with osteosarcoma (OS).

 

 

14/03/2013
PET/CT imaging in neuroblastoma

Autore: A. Piccardo, E. Lopci, M. Conte, L. Foppiani, A. Garaventa, M. Cabria, G. Villavecchia, S. Fanti, A. Cistaro

123 Iodine-metaiodobenzylguanidine (123 I-MIBG) scintigraphy is currently the tracer of choice for neuroblastoma (NB).

 

 

22/02/2013
ositron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series

Autore: G. B. Piccoli, V. Arena, V. Consiglio, M. C. Deagostini, E. Pelosi, A. Douroukas, D. Penna, G. Cortese

Intracystic infection, in Autosomal Dominant Polycystic Kidney Disease (ADPKD) and in kidneys with multiple cystis, is a diagnostic and therapeutic challenge...

 

 

22/02/2013
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study

Autore: E. Pelosi, D. Penna, A. Douroukas, M. Bellò, A. Amati, V. Arena, R. Passera, G. Bisi

Aim. To compare the accuracy of bone marrow biopsy (BMb) and positron emission tomography (PET) in bone marrow disease (BMD) detection, in a large multicentre population of patients with new diagnosis of malignant lymphoma.

 

 

13/11/2011
Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review

Autore: A. Skanjeti, E. Pelosi

Due to its prevalence, prostate cancer represents a serious health problem. The treatment, when required, may be...

 

 

27/05/2011
Nonossifying fibroma: A possible pitfall in F18-FD- PET/CT imaging of Hodgkin's disease

Autore: M. Pagano, M. Berta, A. M. Postini, M. Bianchi, A. Brach del Prever, C. Defilippi, U. Ficola, A. Cistaro

A 14-year-old girl was examined for a right lateral neck swelling and radiographic mediastinal widening...

 

 

11/05/2011
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease

Autore: E. Lopci, R. Burnelli, L. Guerra, A. Cistaro, A. Piccardo, P. Zucchetta, E. Derenzini, A. Todesco, A. Garaventa, F. Schumacher, P. Farruggia, S. Buffardi, A. Sala, F. Casale, P. Indolfi, S. Biondi, A. Pession, S. Fanti

In this retrospective study, 98 paediatric patients with HD (enrolled in eight Italian centres) were analysed.

 

 

07/03/2011
Role of integrated PET/CT with [(18)F]-FDG in the management of patients with fever of unknown origin: a single-centre experience

Autore: E. Pelosi, A. Skanjeti, D. Penna, V. Arena

Fever of unknown origin (FUO) is a diagnostic challenge for the wide range of possible causes involved

 

 

14/02/2011
Assessment of a new 18F-FDG PET/CT protocol in the staging of oral cavity carcinomas

Autore: A. Cistaro, S. Palandri, V. Balsamo, G. Migliaretti, M. Pentenero, C. Testa, S. Cusmà, F. Ceraudo, S. Gandolfo, U. Ficola

Because image fusion using (18)F-FDG PET/CT allows a better localization of the pathologic uptake...

 

 

01/09/2010
Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study

Autore: E. Pelosi, D. Penna, A. Douroukas, M. Bellò, A. Amati, V. Arena, R. Passera, G. Bisi

In patients with malignant lymphoma the histological definition and the accurate staging are crucial elements in order to plan the best therapeutic regimen...

 

 

09/08/2010
Amyotrophic Lateral Sclerosis–Frontotemporal Lobar Dementia in 3 Families With p.Ala382Thr TARDBP Mutations

Autore: A. Chiò, A. Calvo, C. Moglia, G. Restagno, I. Ossola, M. Brunetti, A. Montuschi, A. Cistaro, A. Ticca, B. J. Traynor, J. C. Schymick, R. Mutani, M.G. Marrosu, M.R. Murru, G. Bor

Tratto da: WWW.ARCHNEUROL.COMTAR DNA-binding protein 43, encoded by the TARDBP gene, has been identified as...

 

 

03/11/2009
Expansive Masses Arising From The Clivus: The Role Of FDG-PET/CT In The Metabolic Assessment Of Skeletal Lesions

Autore: A. Cistaro, S. Durando, F. Pazè, A. Limberti, M. Cogoni, C. Juenemann, I. Morra, M. C. Valentini

A patient with neurological symptoms underwent CT scan that showed a sellar and suprasellar mass with bone erosions...

 

 

01/01/2009
Impiego di 2-fluoro-2-deossi-D-glucosio marcato nell’imaging nucleare: effetti su una possibile contaminazione batterica

Autore: Rita Mangiapane, Angelina Cistaro, Alessandro Sperandeo, Antonino D’Agata, Nicola Paligoric, Francesco Cocheo, Domenico Lo Gerfo, Raffaella Recenti, Umberto Ficola

Tratto da: Biochimica clinica vol. 33, n. 6 La tomografia ad emissione di positroni (PET) è un esame diagnostico non invasivo di medicina nucleare...

 

 

14/05/2008
Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma

Autore: M. Pentenero, A. Cistaro, M. Brusa, M. M. Ferraris, C. Pezzuto, R. Carnino, E. Colombini, M. C. Valentini, L. Giovanella, G. Spriano, S. Gandolfo

In the treatment of oral squamous cell carcinoma (OSCC), preservation of organs and functions such as...

 

 

03/04/2008
Fluorodeoxyglucose-positron emission tomography/computed tomography in the staging and evaluation of treatment response in a patient with Castleman's disease: a case report

Autore: E. Pelosi, A. Skanjeti, A. Cistaro, V. Arena

Tratto da: Journal of Medical Case Reports

Castleman's disease is a rare lymphatic polyclonal disorder that is characterised by...

 

 

01/03/2008
FDG-PET in the detection of bone marrow disease in Hodgkin's desease and aggressive non-Hodgkin's lymphoma and its impact on clinical management

Autore: E. Pelosi, D. Penna, D. Deandreis, A. Chiappella, A. Skanjeti, U. Vitolo, G. Bisi

Tratto da: Quarterly Journal n. 1 vol. 52

Lymphomas comprise a group of neoplasms in which therapeutic management and prognosis strongly depend on the stage of the desease at diagnosis.

 

 

29/08/2007
La Radiologia medica volume 113 numero 4 (prostata)

Autore: E. Pelosi, V. Arena, A. Skanjeti, V. Pirro, A. Douroukas, A. Pupi, M. Mancini

Ruolo dell’esame PET/TC con 18F-colina nell’identificazione di malattia in pazienti sottoposti a trattamento radicale per neoplasia prostatica, con attuale recidiva biochimica.

 

 

29/05/2007
La Radiologia medica volume 113 numero 4 (linfomi)

Autore: E. Pelosi, D. Pregno, D. Penna, D. Deandreis, A. Chiappella, G. Limerutti, U. Vitolo, M. Mancini, G. Bisi, E. Gallo

Stadiazione dei linfomi di Hodgkin e dei linfomi non-Hodgkin aggressivi: ruolo dell’esame PET/TC total body con 18F-fluorodesossiglucosio e confronto con le tecniche convenzionali di stadiazione.

 

 

01/01/2007
18F-Fluorodeoxyglucose-Positron Emission Tomography in the Characterization of Suspected Rhabdoid Renal Tumor Recurrence: A Case Report

Autore: V. Pirro, A. Skanjeti, E. Pelosi

Tratto da: J Pediatr Hematol Oncol, Volume 29, Number 1 Rhabdoid tumor is a rare, aggressive, and undifferentiated cancer, that can be localized in the central nervous system, in the thorax or in the kidney.

 

 

11/10/2006
The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer

Autore: E. Pelosi, D. Deandreis

Tratto da: EJSO the journal of Cancer Surgery

In patients with colorectal cancer an accurate diagnostic work-up is mandatory in order to perform the most specific treatment.

 

 

01/03/2006
Role of whole body positron emission tomography computed...

Autore: E. Pelosi, M. Pennone, D. Deandreis, A. Douroukas, M. Mancini, G. Bisi

Tratto da: Quarterly Journal n. 1 vol. 50

The site of origin of a histologically documented carcinoma is not identified clinically...

 

 

01/05/2004
Recurrent Hepatoblastoma in OrthotopicTransplanted Liver: Detection with FDG Positron Emission Tomography

Autore: S. Sironi, C. Messa, A. Cistaro, C. Landoni, M. Provenzi, E. Giraldi, A. Sonzogni, F. Fazio

Tratto da: AJR Hepatoblastoma is the most common malignant hepatic tumor in...

 

 

12/2012
PET in the clinical work-up of patients with spondylodiscitis: a new tool for the clinician

Skanjeti A, Penna D, Douroukas A, Cistaro A, Arena V, Leo G, Longo G, Traverso A, Belloro S, Pelosi E. Q J Nucl Med Mol Imaging. 2012

Dec;56(6):569-76. PubMed PMID: 23358410.

 

 

17/09/2012
Diffuse neoplasms of the pleural serosa.

Cardinale L, Ardissone F, Asteggiano F, Laugelli EM, Penna D, Fava C.

Radiol Med. 2013 Apr;118(3):366-78. doi: 10.1007/s11547-012-0877-8. Epub 2012 Sep 17. Review. PubMed PMID: 22986697.

 

 

11/06/2012
Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.

Billè A, Okiror L, Skanjeti A, Errico L, Arena V, Penna D, Ardissone F, Pelosi E.

Eur J Cardiothorac Surg. 2013 Mar;43(3):574-9. doi: 10.1093/ejcts/ezs366. Epub 2012 Jun 11. PubMed PMID: 22689182.

 

 

07/06/2012
The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases.

Billè A, Okiror L, Skanjeti A, Errico L, Arena V, Penna D, Ardissone F, Pelosi E. Clin Lung Cancer. 2013 Mar;14(2):149-56. doi: 10.1016/j.cllc.2012.04.007. Epub 2012 Jun 7. PubMed PMID: 22682667.

 

 

29/09/2011
Positron emission tomography in the diagnostic pathway for intracystic infection in adpkd and "cystic" kidneys. a case series.

Piccoli GB, Arena V, Consiglio V, Deagostini MC, Pelosi E, Douroukas A, Penna D, Cortese G.

BMC Nephrol. 2011 Sep 29;12:48. doi: 10.1186/1471-2369-12-48. PubMed PMID: 21957932; PubMed Central PMCID: PMC3197475.

 

 

02/2009
Dual-phase F-18 FDG PET/CT scanning in the suspicion of relapse of ovarian neoplasia.

Penna D, Varetto T, Deandreis D, Castellano G, Bisi G. Clin Nucl Med. 2009 Feb;34(2):111-3. doi: 10.1097/RLU.0b013e318192c3cc. PubMed PMID: 19352268.